These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23301500)

  • 1. Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus.
    Selvarajah S; Uiterwaal CS; Haniff J; van der Graaf Y; Visseren FL; Bots ML;
    Eur J Clin Invest; 2013 Feb; 43(2):198-207. PubMed ID: 23301500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24).
    Drion I; van Hateren KJ; Joosten H; Alkhalaf A; Groenier KH; Kleefstra N; Wetzels JF; Bilo HJ
    Age Ageing; 2012 May; 41(3):345-50. PubMed ID: 22314695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study.
    Nag S; Bilous R; Kelly W; Jones S; Roper N; Connolly V
    Diabet Med; 2007 Jan; 24(1):10-7. PubMed ID: 17227319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
    Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
    Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals.
    Targher G; Zoppini G; Chonchol M; Negri C; Stoico V; Perrone F; Muggeo M; Bonora E
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):294-301. PubMed ID: 20096544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
    Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
    Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
    Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
    Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria.
    Agarwal R; Debella YT; Giduma HD; Light RP
    Nephrol Dial Transplant; 2012 Jan; 27(1):310-7. PubMed ID: 21669884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used?
    Fabbian F; De Giorgi A; Monesi M; Pala M; Tiseo R; Misurati E; Parisi C; Volpi R; Graziani R; Mikhailidis DP; Manfredini R
    Diab Vasc Dis Res; 2015 Jan; 12(1):46-52. PubMed ID: 25344129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
    Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
    Sasso FC; Chiodini P; Carbonara O; De Nicola L; Conte G; Salvatore T; Nasti R; Marfella R; Gallo C; Signoriello S; Torella R; Minutolo R;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease.
    Smith GL; Shlipak MG; Havranek EP; Foody JM; Masoudi FA; Rathore SS; Krumholz HM
    Arch Intern Med; 2006 May; 166(10):1134-42. PubMed ID: 16717177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.